Updated:
Dievini Hopp
Dietmar Hopp established the office in 2005 after building SAP into a global enterprise-software leader. The structure channels patient capital from that...
Dievini Hopp
Dietmar Hopp established the office in 2005 after building SAP into a global enterprise-software leader. The structure channels patient capital from that fortune into life sciences. Dievini Hopp targets innovative therapy and diagnostic platforms in oncology, neurology, infectiology and cell therapy. It also backs molecular diagnostics for personalized medicine. Investments occur through direct co-investments and SPVs, primarily in Germany and Europe, with support extended for worldwide development and commercialization. Confirmed co-investors include the Bill & Melinda Gates Foundation and KfW on CureVac. The office maintains no disclosed headcount or additional locations beyond Walldorf. Adjacent holdings include Golf Club St. Leon-Rot, Domaine de Terre Blanche, SAP Arena, TSG 1899 Hoffenheim and Adler Mannheim. The Dietmar Hopp Stiftung handles separate philanthropic activity. The firm operates as a dedicated biotech holding company rather than a diversified family office, embedding operational involvement in portfolio companies from seed through later stages.
General information
Firm type
Single Family Office
Year founded
2005
Location
Region
Europe
Country
Germany
City
Walldorf
Corporate office
Walldorf, Germany
Principals
Dietmar Hopp
Founder
Daniel Hopp
Family Member
Oliver Hopp
Family Member
Sector focus
Frequently asked questions
Who runs investment decisions at Dievini Hopp?
Dietmar Hopp serves as founder and principal. Family members Daniel Hopp and Oliver Hopp oversee specific operating assets outside the core biotech portfolio.
How does Dievini Hopp source proprietary deal flow?
The office focuses on early-stage European biotechnology and medical technology opportunities. It maintains direct relationships with management teams in oncology, neurology and personalized diagnostics.
Is Dievini Hopp structured as a single family office or does it operate more like a venture firm?
It functions as a single family office but uses a dedicated biotech holding company structure. This enables active strategic support alongside capital deployment.
Does Dievini Hopp participate in fund commitments or only direct deals?
The office executes direct co-investments and SPVs. No fund commitments are disclosed in available records.
What investment stages does Dievini Hopp typically target?
It targets startup and early-stage companies with capacity for follow-on rounds through later development phases.
Where does the underlying wealth come from?
The capital originates from Dietmar Hopp’s founding stake in SAP, the enterprise-software company.
Does Dievini Hopp maintain philanthropic structures, and how are they separated?
The Dietmar Hopp Stiftung operates as a distinct philanthropic vehicle. It remains separate from the investment activities of the family office.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: